Insights from 2023 ASCO® Annual Meeting
Head and Neck
Insights from 2023 ASCO® Annual Meeting
Enfortumab Vedotin in the Previously Treated Advanced Head & Neck Cancer Cohort of EV-202
FEATURING
Paul Swiecicki
- 233 views
- June 29, 2023
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL-IMMUNE & DEPEND"
FEATURING
Paolo Bossi
- 938 views
- June 16, 2023
- 6
Insights from 2023 ASCO® Annual Meeting
Immunotherapy Trials for Nasopharyngeal Cancers
FEATURING
Nabil Saba
- 402 views
- June 16, 2023
- 3